Christopher Lee is an associate in the Los Angeles office of Gibson, Dunn & Crutcher, where he currently practices in the firm’s Corporate Department. His practice focuses on mergers and acquisitions, and his experience includes representation of public and private companies in general corporate governance matters and complex business transactions.
He received his juris doctor degree from Yale Law School and served as a teaching assistant for Corporate Finance at the Yale School of Management. Christopher graduated cum laude from Yale University with a bachelor’s degree in political science with distinction.
Selected representative experience:*
- Edwards Lifesciences in its acquisition of Endotronix, a leader in heart failure (HF) management solutions
- Abu Dhabi Investment Authority in its investment in MHS Global, a leading global provider of material handling automation technology and systems integration, and FORTNA, a leading software and solutions provider for warehouse and distribution
- Fortress Investment Group in its acquisition of Vice Media, together with Soros Fund Management and Monroe Capital
- Aurora Capital Partners in its acquisition of Universal Pure Holdings, LLC, a leading provider of high pressure processing and related food safety and technical services
- The Chernin Group in its majority investment in BiggerPockets, a leading educational platform providing access to real estate investing
- Candle Media, a Blackstone-backed media company, in its acquisition of socially progressive media company ATTN:
- A publicly traded biopharmaceutical company in its US$6.5 billion sale to a global biopharmaceutical company
- A publicly traded high-technology sensors solutions company in its US$1.7 billion acquisition of a publicly traded test systems and sensors company and subsequent US$700 million sale of a division of that company
- A publicly traded biotechnology company in its US$2.7 billion acquisition of a 20.5% stake in a publicly traded biotechnology company
- A publicly traded homebuilding company in its US$2.5 billion sale to a publicly traded homebuilding company
- A publicly traded healthcare company in connection with its US$4.9 billion sale of a business segment
- A virtual behavioral health company in its US$1.4 billion deSPAC merger
- A global asset manager in its acquisition of a real estate asset manager managing over US$100 billion in assets
- A publicly traded biopharmaceutical company in its US$1.5 billion acquisition of products from a global pharmaceutical company
- A buyer consortium in its US$1.1 billion acquisition of a publicly traded internet content and marketing service provider
* Includes matters handled prior to joining Gibson, Dunn & Crutcher
Prior to joining Gibson Dunn, Chris practiced with Latham & Watkins. He is admitted to practice in California.
Capabilities
- Mergers and Acquisitions
- Capital Markets
- Emerging Companies / Venture Capital
- Private Equity
- Securities Regulation and Corporate Governance
Credentials
Education:
- Yale University - 2016 Juris Doctor
- Yale University - 2012 Bachelor of Arts
Admissions:
- California Bar